Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
0775:HKG
CK Life Sciences Intl (Holdings) Inc
HK$0.73
-1.35%
(-0.0100) 1D
Apr 24, 11:00:15 AM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 0775...
Open
HK$0.73
High
HK$0.73
Low
HK$0.72
Mkt. cap
7.02B
Avg. vol.
4.25M
Volume
332.21K
52-wk high
HK$1.10
52-wk low
HK$0.64
EPS
-HK$0.02
Shares outstanding
9.61B
No. of employees
2K
News stories
From sources across the web
Profile
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings. It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008. CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector. The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
About CK Life Sciences Intl (Holdings) Inc
CEOYing Choi Yu
Employees1.94K
Founded2000
Headquarters-
SectorBiotechnology
Websiteck-lifesciences.com
Previous reportsAll values in HKD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in HKD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.30B
1.30B
1.40B
1.40B
Cost of goods sold
906.10M
906.10M
1.01B
1.01B
Cost of revenue
906.10M
906.10M
1.01B
1.01B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
165.82M
165.82M
187.01M
187.01M
Operating expense
413.65M
413.65M
440.32M
440.32M
Total operating expenses
1.32B
1.32B
1.45B
1.45B
Operating income
-16.84M
-16.84M
-48.67M
-48.67M
Other non operating income
15.63M
15.63M
16.60M
16.60M
EBT including unusual items
-67.43M
-67.43M
58.42M
58.42M
EBT excluding unusual items
-67.38M
-67.38M
-87.93M
-87.93M
Income tax expense
7.99M
7.99M
77.23M
77.23M
Effective tax rate
-11.85%
-11.85%
132.19%
132.19%
Other operating expenses
226.33M
226.33M
231.88M
231.88M
Net income
-75.42M
-75.42M
-17.98M
-17.98M
Net profit margin
-5.79%
-5.79%
-1.28%
-1.28%
Earnings per share
-
-
-
-
Interest and investment income
5.24M
5.24M
5.36M
5.36M
Interest expense
-71.65M
-71.65M
-61.80M
-61.80M
Net interest expenses
-66.40M
-66.40M
-56.44M
-56.44M
Depreciation and amortization charges
20.90M
20.90M
20.80M
20.80M
EBITDA
4.66M
4.66M
-27.18M
-7.06M
Gain or loss from assets sale
-
-
-
-346.73M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer